Intervention not reported
Death · patients with HIV‐1 infection and a pre‐established clinical need for treatment with an antiretroviral drug regimen containing abacavir…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in severity · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Adverse events · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Quality of life · infantile seborrhoeic dermatitis (including cradle cap)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in severity · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Adverse events · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Quality of life · infantile seborrhoeic dermatitis (including cradle cap)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in severity · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Adverse events · infantile seborrhoeic dermatitis (including cradle cap)
1 finding from 1 review
Quality of life · infantile seborrhoeic dermatitis (including cradle cap)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants achieving clear or almost clear skin (PASI 90 to 100 or PGA 0 to 1) · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Percentage of participants with adverse effects and severe adverse effects · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of relapses of guttate psoriasis or flares within a period of 6 months after the treatment has finished · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants achieving PASI 75 or PGA 1 to 2 · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in participant satisfaction measures and quality of life assessment measures Overall subjective score on 5 items (appearance of lesions, impairment of daily life, pruritus, burning, and pain) reported through figures · guttate psoriasis
1 finding from 1 review
Time‐to‐resolution: achieving PASI 90 to 100 or PGA 0 to 1 · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · guttate psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time‐to‐resolution: achieving PASI 90 to 100 or PGA 0 to 1 · people with chronic plaque psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with adverse events and severe adverse events · people with chronic plaque psoriasis
1 finding from 1 review
Proportion of participants achieving clear or almost clear skin (PASI 90 to 100 or PGA 0 to 1) · people with chronic plaque psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found